Kevin Sheng-Kai Ma, DDS, FRSPH, FRSM, international scholar at the Center for Global Health at the Perelman School of Medicine at the University of Pennsylvania and lead author of this study, told Medical News Today that he and his colleagues were not surprised by these findings, as these [obesity and obesity-related issues] are indications for GLP-1RA that have been approved in recent years. That said, clinicians are encouraged to monitor and continue assessing patients receiving GLP-1RA [drugs], he advised
Successful outcomes require more than weekly injections
People who follow a healthy diet and exercise regularly while taking oral GLP-1 medications often see even better results than the average clinical trial outcomes
A study showed high dose intranasal glutathione to improve Parkinsonss symptoms, but the results were not statistically significant
Nexiras Carolean , a clean-label, ingredient derived from cactus and carob , supports GLP-1 secretion by achieving peak viscosity within 15 minutes delivering satiety through delayed gastric emptying and sustained digestive benefits